Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Todays Updates


COMP360 Psilocybin NDA Submitted to FDA for Treatment-Resistant Depression


COMP360 Psilocybin NDA Submitted to FDA for Treatment-Resistant Depression

Philadelphia Forum Explores Diagnostic Delays and Biologic Sequencing in Myasthenia Gravis Chafic Karam, MD


At a NeurologyLive Clinical Forum in Philadelphia, Pennsylvania, Chafic Karam, MD, chief of neuromuscular medicine at Penn Medicine, discussed treatment sequencing in myasthenia gravis.

NeurologyLive® Friday 5 — November 13, 2026 Isabella Ciccone, MPH


Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 13, 2026.

From Glucose to Cognition: Where Repurposed Diabetes Drugs Stand in Alzheimer Disease Marco Meglio


As diabetes drugs are tested for repurposing in Alzheimer disease, the negative phase 3 EVOKE and EVOKE+ results for oral semaglutide have moved attention toward prevention and earlier, combination-based approaches.

Myelin Repair Research in MS: Lessons From Clinical Trials and the Road Ahead Nick Cunniffe, MD, PhD, Louie Pasculli


Nick Cunniffe, MD, PhD, assistant professor and consultant neurologist at the University of Cambridge, discusses lessons from a decade of proof-of-concept remyelination trials in MS.

NeurologyLive® Brain Games: November 15, 2026 Louie Pasculli


Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is National Epilepsy Awareness Month!

Todays Updates


COMP360 Psilocybin NDA Submitted to FDA for Treatment-Resistant Depression


COMP360 Psilocybin NDA Submitted to FDA for Treatment-Resistant Depression

Philadelphia Forum Explores Diagnostic Delays and Biologic Sequencing in Myasthenia Gravis Chafic Karam, MD


At a NeurologyLive Clinical Forum in Philadelphia, Pennsylvania, Chafic Karam, MD, chief of neuromuscular medicine at Penn Medicine, discussed treatment sequencing in myasthenia gravis.

NeurologyLive® Friday 5 — November 13, 2026 Isabella Ciccone, MPH


Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 13, 2026.

From Glucose to Cognition: Where Repurposed Diabetes Drugs Stand in Alzheimer Disease Marco Meglio


As diabetes drugs are tested for repurposing in Alzheimer disease, the negative phase 3 EVOKE and EVOKE+ results for oral semaglutide have moved attention toward prevention and earlier, combination-based approaches.

Myelin Repair Research in MS: Lessons From Clinical Trials and the Road Ahead Nick Cunniffe, MD, PhD, Louie Pasculli


Nick Cunniffe, MD, PhD, assistant professor and consultant neurologist at the University of Cambridge, discusses lessons from a decade of proof-of-concept remyelination trials in MS.

NeurologyLive® Brain Games: November 15, 2026 Louie Pasculli


Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is National Epilepsy Awareness Month!

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A small rise in cancer was observed following the 1986 Chernobyl accident.

2.

CAR-T Induces Deep, Durable Remission in Smoldering Myeloma

3.

Prostate cancer, rectal exams, Casgevy approved for thalassemia, and two million cancer cases.

4.

Drug Combo's Response Rates Top 90% in Small Cell Lung Cancer Trial

5.

Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot